Infantile atopic dermatitis – increasing severity predicts negative impacts on maternal and infant sleep: a mixed methods study

Simple item page
dc.contributor.authorHarbottle, Zoe
dc.contributor.authorNötzel, Amanda
dc.contributor.authorGolding, Michael A.
dc.contributor.authorBhamra, Manvir
dc.contributor.authorKopsch, Isac
dc.contributor.authorWilking, Erik
dc.contributor.authorJonsson, Marina
dc.contributor.authorAbrams, Elissa M.
dc.contributor.authorHalbrich, Michelle A.
dc.contributor.authorSimons, Elinor
dc.contributor.authorRoos, Leslie E.
dc.contributor.authorKeddy-Grant, Jill A.
dc.contributor.authorGerstner, Thomas V.
dc.contributor.authorSt-Vincent, Jo-Anne
dc.contributor.authorEkström, Sandra
dc.contributor.authorProtudjer, Jennifer L.
dc.date.accessioned2024-04-01T16:49:30Z
dc.date.available2024-04-01T16:49:30Z
dc.date.issued2024-03-22
dc.date.updated2024-04-01T06:26:39Z
dc.description.abstractBackground While the impacts of atopic dermatitis (AD) on maternal and child sleep outcomes have been previously explored, less is known about the associations between infantile AD and sleep quality and quantity. Objective To describe the perceived causes of AD-associated maternal sleep disturbances and the association between AD severity and infant sleep outcomes. Methods Mothers with infants aged < 19 months old with a diagnosis of AD were recruited from social media and medical clinics in Winnipeg, Canada between October 2021 and May 2022. Infant AD severity was classified using maternal-reported data on the Patient-Oriented Scoring Atopic Dermatitis tool (PO-SCORAD). Quantitative data were collected via a series of questionnaires with a subset of mothers subsequently completing semi-structured interviews. Quantitative and qualitative data were integrated in the discussion. Results Mothers of infants with moderate/severe AD (6/12) were more likely to report their infant suffering from a higher degree of sleeplessness (i.e., ≥ 5 on a scale of 0–10) over the past 48 h compared to mothers of infants with mild AD (0/18). This was supported by qualitative findings where mothers described how their infant’s sleep quality and quantity worsened with AD severity. Additionally, 7/32 mothers reported that their child’s AD, regardless of severity, disturbed their sleep. Maternal sleep loss was most commonly attributed to infant itching (6/7), followed by worry (4/7). Conclusion Infantile AD severity was associated with worse sleep outcomes for both mothers and infants. We propose that maternal and infantile sleep quality and quantity can be improved by reducing AD severity through adherence to topical treatments.
dc.identifier.citationAllergy, Asthma & Clinical Immunology. 2024 Mar 22;20(1):21
dc.identifier.doi10.1186/s13223-024-00883-x
dc.identifier.urihttp://hdl.handle.net/1993/38121
dc.language.isoeng
dc.language.rfc3066en
dc.publisherBMC
dc.rightsopen accessen_US
dc.rights.holderThe Author(s)
dc.subjectAtopic dermatitis
dc.subjectInfant sleep
dc.subjectMaternal sleep
dc.subjectMixed methods
dc.subjectSleep disturbance
dc.titleInfantile atopic dermatitis – increasing severity predicts negative impacts on maternal and infant sleep: a mixed methods study
dc.typeJournal Article
local.author.affiliationRady Faculty of Health Sciences::Max Rady College of Medicine::Department of Pediatrics and Child Health
oaire.citation.issue21
oaire.citation.titleAllergy, Asthma & Clinical Immunology
oaire.citation.volume20
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13223_2024_Article_883.pdf
Size:
1.14 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
770 B
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works